Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists track arthritis drug to catch missed doses

NCT ID NCT03852888

Summary

This study aimed to better understand how patients with rheumatoid arthritis process their key medication, methotrexate. Researchers tracked the drug and its byproduct in the urine of 62 patients who were taking their weekly dose correctly. The goal was to establish a normal pattern to later help doctors identify patients who might be missing their medication.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chu Reims

    Reims, 51092, France

Conditions

Explore the condition pages connected to this study.